Malaria Research and Treatment / 2015 / Article / Tab 1 / Clinical Study
Efficacy and Safety of Artesunate-Amodiaquine versus Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium falciparum Malaria in Sentinel Sites across Côte d’Ivoire Table 1 Baseline characteristics of recruited patients (Day 1).
ASAQ AL Global 143 146 Number of patients 289 Sex M, (% ) 63 (44.1 ) 71 (48.6 ) 0.508 134 (46.4 ) F, (% ) 80 (55.9 ) 75 (51.4 ) 155 (53.6 ) Mean age (SD) years 8.87 (9.09 ) 8.06 (6.72 ) 0.389 8.46 (7.98) Min-max 2–63 2–52 2–63 2–5 , (% )69 (48.3 ) 62 (42.5 ) 131 (45.3 ) 5–15 , (% )57 (39.9 ) 73 (50.0 ) 130 (45.0 ) 15–63 , (% )17 (11.9 ) 11 (7.5 ) 28 (9.7 ) Mean temperature (SD) °C 38.8 (0.84) 38.9 (0.94) 0.341 38.84 (0.89) Min-max 37.5–44.6 37.5–41.2 37.5–41.2 37,5–38,5 , (% )62 (43.4 ) 63 (43.2 ) 125 (43.3 ) 38,5–41,2 , (% )81 (56.6 ) 83 (56.8 ) 164 (56.7 ) Mean parasitaemia (SD) tpz/μ L 51200 (58259) 51300 (56603) 0.963 51200 (57328) (écart-type) tpz/μ L Min-max 2108–200000 2000–200000 2000–200000 Gametocyte carrier rate, (% ) 5 (3.50 ) 2 (1.37 ) 0.428 7 (2.42 ) Mean AST (SD) UI/L 34.66 (19.40) 36.50 (20.43) 0.433 35.59 (19.92) Min-max 6–109 4–153 4–153 Mean ALT (SD) UI/L 23.01 (14.26) 23.07 (13.96) 0.971 23.04 (14.09) Min-max 5.29–88 5–87.6 5–88 Mean creatinine (SD) mg/L 8.45 (2.97) 8.00 (2.18) 0.143 8.22 (2.61) Min-max 4.00–21.87 3.95–13.72 3.95–21.87 Mean bilirubin (SD) mg/L 9.23 (7.65) 8.66 (8.71) 0.555 8.94 (8.20) Min-max 1–38.64 1.07–53.57 1–53.57 Mean haemoglobin (SD) g/dL 10.00 (1.75) 10.02 (1.89) 0.926 10.01 (1.82) Min-max 6–14.3 6–19 6–19
Independent samples -test.